Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (151-160 of 287) with videos related to

Pageof 29
Sort By:
The Journal of Experimental Medicine|May 1, 1994
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59M Parizade, R Arnon, P J Lachmann, et al.
Journal of Immunological Methods|August 30, 1992
A cleavable biotinylating agent and its use in protein electroblotsM J Hobart, B A Fernie, P J Lachmann
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1993
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challengeS M McHugh, P J Lachmann, P W Ewan
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3M C Poznansky, P M Clissold, P J Lachmann
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cellsW Emlen, G Burdick, V Carl, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
The Journal of Experimental Medicine|August 1, 1977
C6: synthesis by the liver in vivoM J Hobart, P J Lachmann, R Y Calne
Ciba Foundation Symposium|January 1, 1986
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animalsP J Lachmann, L Strangeways, A Vyakarnam, et al.
Clinical and Experimental Immunology|February 1, 1990
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationP A Gatenby, J E Barbosa, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Pageof 29

Showing results (151-160 of 287) with videos related to

Sort By:
Pageof 29
The Journal of Experimental Medicine|May 1, 1994
Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59M Parizade, R Arnon, P J Lachmann, et al.
Journal of Immunological Methods|August 30, 1992
A cleavable biotinylating agent and its use in protein electroblotsM J Hobart, B A Fernie, P J Lachmann
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 1, 1993
Peripheral blood mononuclear cells from house dust mite allergic patients produce IL-2 in response to specific allergen challengeS M McHugh, P J Lachmann, P W Ewan
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
The difference between human C3F and C3S results from a single amino acid change from an asparagine to an aspartate residue at position 1216 on the alpha-chain of the complement component, C3M C Poznansky, P M Clissold, P J Lachmann
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cellsW Emlen, G Burdick, V Carl, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J Lachmann
The Journal of Experimental Medicine|August 1, 1977
C6: synthesis by the liver in vivoM J Hobart, P J Lachmann, R Y Calne
Ciba Foundation Symposium|January 1, 1986
Raising antibodies by coupling peptides to PPD and immunizing BCG-sensitized animalsP J Lachmann, L Strangeways, A Vyakarnam, et al.
Clinical and Experimental Immunology|February 1, 1990
Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitationP A Gatenby, J E Barbosa, P J Lachmann
Clinical and Experimental Immunology|November 1, 1990
A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugatesA M Montgomery, M G Wing, P J Lachmann
Pageof 29